A metabolically engineered bacterium controls autoimmunity by remodeling the pro-inflammatory microenvironment
Das, J. K.; Guo, F.; Hunt, C.; Steinmeyer, S.; Plocica, J. A.; Kobayashi, K. S.; Jayaraman, A.; Ficht, T. A.; Alaniz, R. C.; de Figueiredo, P.; Song, J.
Show abstract
Immunotherapy has led to impressive advances in the treatment of autoimmune and pro-inflammatory disorders; yet, its clinical outcomes remain limited by a variety of factors including the pro-inflammatory microenvironment (IME). Discovering effective immunomodulatory agents, and the mechanisms by which they control disease, will lead to innovative strategies for enhancing the effectiveness of current immunotherapeutic approaches. We have metabolically engineered an attenuated bacterial strain (i.e., Brucella melitensis 16M {Delta}vjbR, Bm{Delta}vjbR) to produce indole, a tryptophan metabolite that controls the fate and function of regulatory T cells (Tregs). We demonstrated that treatment with this strain polarized M2 macrophages (M{varphi}) which produced anti-inflammatory cytokines (e.g., IL-10) and promoted Treg function; moreover, when combined with adoptive cell transfer (ACT) of Tregs, a single treatment with our engineered bacterial strain dramatically reduced the incidence and score of autoimmune arthritis and decreased joint damage. These findings show how a metabolically engineered bacterium can constitute a powerful vehicle for improving the efficacy of immunotherapy, defeating autoimmunity and reducing inflammation by remodeling the IME and augmenting Treg function.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- MDSC depletion during immunization with heat-killed Mycobacterium tuberculosis increases protection against BCG infection. 96%
- Polymeric Pathogen-like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus 94%
- Bcl6 Preserves the Suppressive Function of Regulatory T Cells during Tumorigenesis 94%
Similar papers in this journal
- Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2 95%
- CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells 95%
- Integration of IL-2 and IL-4 Signals Coordinates Divergent Regulatory T cell Responses and Drives Therapeutic Efficacy 94%
Similar papers in this journal
- Metformin enhances anti-mycobacterial responses by educating immunometabolic circuits of CD8+ T cells 95%
- T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling 94%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 93%
Similar papers in this journal
- Distinct immune-effector and metabolic profile of CD8 + T Cells in patients with autoimmune polyarthritis induced by therapy with immune-checkpoint inhibitors 94%
- Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised Patients 92%
- Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial 91%
Similar papers in this journal
- Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells 95%
- Liver X Receptor regulates Th17 and RORγt+ Treg cells by distinct mechanisms 94%
- MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responses 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.